Pharma Wholesaler Fights To Overturn UK Price-Fixing Fine

Law360, London (November 16, 2020, 5:20 PM GMT) -- A British drug wholesaler fighting a fine for rigging the market for an antidepressant accused the Competition and Markets Authority on Monday of spinning an anti-competitive plot from texts that only vaguely mentioned prices and supplies.

Mark Brealey QC, counsel for Luxon UK Ltd., told the Competition and Appeals Tribunal that the antitrust regulator had "embellished" text messages that were otherwise "innocuous" to rationalize its decision to fine the company £1.2 million ($1.6 million) in March.

The company is appealing the CMA's findings that it shared information with rivals to keep the price of nortriptyline tablets artificially high. The company has argued...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!